Paralympic Winter Games PyeongChang 2018 – Anti-Doping Information

The Canadian Centre for Ethics in Sport (CCES) is committed to providing Team Canada athletes with the anti-doping information they need for the 2018 Winter Paralympic Games (the Games) in PyeongChang. The following is a reminder about the anti-doping rules and responsibilities that apply to Team Canada athletes at all times and specific information for these Games.

Anti-Doping Rules

The International Paralympic Committee (IPC) Anti-Doping Code will be in force for the Games. The Games period begins on March 3, 2018 (the opening of the Athletes Village) and ends on March 18, 2018 (the closing ceremonies). During that time, athletes may be subject to testing by the IPC. As always, athletes may be notified of their selection for doping control at any time and in any place in the world, with no advance notice.

World Anti-Doping Agency Prohibited List

The World Anti-Doping Agency’s (WADA) 2018 Prohibited List is now public and came into effect on January 1, 2018.

According to the IPC Doping Control Guide for PyeongChang 2018, samples collected during the 12 hours prior to competition through to the end of a competition will be analyzed for all substances and methods on the 2018 WADA Prohibited List. A competition is equal to a single race, match or game.

Samples collected outside of an athlete’s competition period will be analyzed for those substances and methods that are prohibited out of competition only.

Doping Control Rights During the Games

During the Games, and consistent with the athlete rights and responsibilities under the Canadian Anti-Doping Program (CADP), Team Canada athletes are:

  • Encouraged to bring someone with them to doping control to act as their representative and to assist with translation or interpretation as needed,
  • Encouraged to record their concerns regarding the doping control process in a Supplementary Report (if available) or on the Doping Control Form in the “Comments” area,
  • Reminded that once notified for doping control, they must report to the doping control station immediately unless they request a delay for a valid reason and it is approved by the PyeongChang 2018 Anti-Doping Team.

Valid reasons for requesting a delay in reporting to doping control include:

  • Performing a warm-down,
  • Obtaining medical treatment,
  • Fulfilling media commitments,
  • Completing a training session, or
  • Participating in a medal ceremony.

If an athlete is granted a delay in reporting to the doping control station, or a leave from the doping control station, they will be accompanied by a chaperone.

Visit the CCES website for additional anti-doping information including sample collection procedures and athlete rights and responsibilities.


In order to protect clean athletes and increase the efficiency and effectiveness of the fight against doping, the IPC will be collecting Whereabouts information.

The IPC Doping Control Guide for PyeongChang 2018 states that Team Canada athletes who are included in the CCES Registered Testing Pool (RTP), the IPC RTP or the WCF RTP are to continue to update their whereabouts in ADAMS during the Games.

Games-time whereabouts information must include:

  • 60-minute time slot and location for testing,
  • Accommodation details (including building and room number in the Village),
  • Competition schedule, and
  • Training locations and times.

Athletes may appoint a team leader, agent, coach or other who may submit whereabouts information on their behalf, but they remain responsible for the accuracy of their information.

Team Canada athletes in the CCES National Athlete Pool (NAP) and RTP must keep their team leader informed of the following information during the Games:

  • Travel schedules,
  • Accommodation details (including room number in the Village),
  • Competition schedule, and
  • Training locations and times.


As of January 1, 2018, athletes requiring the use of prescription and/or over-the-counter medications must verify the status of all of their medications to determine whether or not they appear on WADA’s 2018 Prohibited List.

While in Canada, Team Canada athletes can check their medications by:

  • Using the GlobalDRO,
  • Emailing
  • Calling the CCES at 1-800-672-7775 (toll free), and
  • Contacting their team physician or the Canadian Paralympic Committee (CPC) physician assigned to their sport.

During the Games, athletes must consult with a CPC team physician regarding their medications.

Therapeutic Use Exemptions

According to the IPC Doping Control Guide, Team Canada athletes who are taking a prohibited substance(s) for medically-justified reasons must have a valid Therapeutic Use Exemption (TUE) in ADAMS prior to the Games.

As of today, to meet the IPC TUE requirements, the CCES recommends that Team Canada athletes with TUEs from the CCES, the IPC or the WCF verify their:

  • TUE expiry date - to ensure it will be valid through the Games period,
  • TUE medication and dosage - to ensure it reflects the current treatment plan,
  • TUE authorizing body - to determine whether or not recognition of the TUE by the IPC is to be sought. Athletes with a CCES or WCF TUE must ensure that the IPC Medical Committee has a copy of their currently valid TUE approval certificate and supporting medical documentation in ADAMS for review by February 1, 2018 in order to begin the recognition process.

Team Canada athletes requiring a TUE must:

  • Prior to February 1, 2018 - should apply to the IPC. Exceptionally, curling athletes must apply to the WCF.
  • From February 1, 2018 - apply directly to the IPC Medical Committee by submitting the completed IPC TUE application with supporting medical documentation either through ADAMS or by email to Team physicians will facilitate this process.

In all cases, it is imperative that athletes keep their team physician and the CPC Chief Medical Officer apprised of their TUE application status.

Athletes can obtain additional TUE information by:

The Use of Catheters

The IPC considers the use of a urinary catheter by an athlete with a need for self-catheterisation as “personal equipment”. There are potential hazards to using different catheters, such as urethral trauma, infection and/or allergic reactions. Athletes who use urinary catheters for urinary sample collection for anti-doping purposes should supply their own catheters. This is the athlete’s responsibility. It is also the athlete’s responsibility to use a catheter in accordance with the manufacturer’s instructions.

PyeongChang 2018 will equip doping control stations with a number of sealed, sterile catheters; however, this will never include all brands, sizes and/or materials. This shall be regarded as a complimentary service offered to athletes.


The IPC Doping Control Guide states that, “Extreme caution is recommended regarding supplement use due to the risk of a positive anti-doping test and/or an adverse health event. The use of supplements by athletes is a concern because in many countries the manufacturing and labelling of supplements may not follow good manufacturing practices or undergo any pre-market regulation for safety or efficacy, as is required for medications, which may lead to a supplement containing declared or undeclared prohibited substances under anti-doping regulations. A significant number of adverse analytical findings globally have been attributed to supplement use”.

The CCES reiterates that there is no way to guarantee that any supplement is free of prohibited substances – even those that do not list a prohibited substance on the label. Athletes are strictly liable for anything found in their sample. Additional information about the doping risks associated with supplement use can be found here.